Skip to content
Screener

Ryan Specialty Holdings RYAN Reporting Segment — G&A

Similar metrics at other companies

Zscaler logo
ZSReportable Segment — G&A
$51.81M+25.6%
Samsara logo
IOTReportable Segment — G&A
$32.05M-28.9%
Snowflake logo
SNOWReportable Segment — G&A
$128.72M-38.6%
Veeva Systems logo
VEEVReportable Segment — G&A
$42.28M+2.2%
Inhibrx Biosciences, Inc. logo
INBXReportable Segment — G&A
$5.71M-5.2%
Bicara Therapeutics logo
BCAXReportable Segment — G&A
$12.74M+70.9%

Other financials

Income statement

See full
Revenue$795.2M+15.2%
Operating income$94.6M-5.6%
Net income$17.6M+164%
EPS (diluted)$0.12-33.8%

Balance sheet

See full
Cash & equivalents$1.5B+13.2%
Total debt$3.8B-2.3%
Total equity$636.2M+17.3%
Total assets$11.0B+11.3%

Cash flow

See full
Operating cash flow-$167.4M-17.2%
CapEx--100%
Free cash flow-$167.4M-16.7%

Valuation

See full
Market cap$5.76B-21.6%
Enterprise value$8.05B-15.1%
P/E53×-79.0×
P/S1.8×-0.8×

Profitability

See full
Operating margin15.5%-1.7pp
Net margin3.4%+1.5pp
FCF margin19.5%+1.2pp

Returns & leverage

See full
Return on equity18.4%+9.2pp
Debt / equity5.9×-1.2×
Current ratio0.0×

Where this comes from

Reported directly by Ryan Specialty Holdings in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: Ryan Specialty Holdings’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:15 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001849253-26-000026
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Fiduciary investment income12,32614,038
Total revenue$795,229$690,166
Compensation-related expense1461,832397,428
General and administrative expense2101,36592,237
Other segment items340,74046,684
Depreciation and amortization69,40267,624
Change in contingent consideration27,294(14,042)
Interest income(1,146)(3,103)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Ryan Specialty Holdings's reporting segment — G&A?
Ryan Specialty Holdings (RYAN) reported reporting segment — G&A of $101.37M in Q1 2026.
How has Ryan Specialty Holdings's reporting segment — G&A changed year-over-year?
Ryan Specialty Holdings's reporting segment — G&A increased by 9.9% year-over-year, from $92.24M to $101.37M.
What is the long-term trend for Ryan Specialty Holdings's reporting segment — G&A?
Over 3 years (2022 to 2025), Ryan Specialty Holdings's reporting segment — G&A has grown at a 28.3% compound annual growth rate (CAGR), from $185.96M to $392.38M.
What does reporting segment — G&A mean?
This includes the overhead costs associated with the daily operations of the segment, such as office rent, technology infrastructure, and professional services. It is a key metric for assessing the segment's cost discipline and operational scalability.

Ask your AI about Ryan Specialty Holdings's reporting segment — g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude